The effect of consumption of milk fermented by Lactobacillus casei strain Shirota on the intestinal microflora and immune parameters in humans

European Journal of Clinical Nutrition

Volumn 52, Issue 12, 1998, Pages 899-907

  Spanhaak, S ^a   Havenaar, R ^a   Schaafsma, G ^a  

^a TNO   (Netherlands)

Author keywords

Fermented milk; Immune system; Intestinal microflora; Lactic acid bacteria; Lactobacillus casei

Indexed keywords

BETA GLUCOSIDASE; BETA GLUCURONIDASE; CYTOKINE;

ADULT; AGED; ARTICLE; BACTERIAL COUNT; BACTERIAL METABOLISM; CELL ACTIVITY; CLOSTRIDIUM; COLONY FORMING UNIT; CONTROLLED STUDY; CYTOKINE PRODUCTION; DIETARY INTAKE; ENZYME ACTIVITY; FECES ANALYSIS; FERMENTATION; HUMAN; HUMAN EXPERIMENT; IMMUNE SYSTEM; INTESTINE FLORA; LACTOBACILLUS BIFIDUS; LACTOBACILLUS CASEI; MALE; MILK; MOISTURE; NATURAL KILLER CELL; NORMAL HUMAN; PHAGOCYTOSIS;

BACTERIA (MICROORGANISMS); BIFIDOBACTERIUM; BIFIDOBACTERIUM BIFIDUM; CLOSTRIDIUM; LACTOBACILLUS CASEI;

EID: 0032416591     PISSN: 09543007     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.ejcn.1600663     Document Type: Article

References (44)

1. Asano M, Karasawa E & Takayama T (1986): Antitumor activity of Lactobacillus casei (LC9018) against experimental mouse bladder tumour (MBT2). J. Urol. 136, 719-721.
2. Aso Y, Akaza H, Kotake T, Imai K, Naito S & the BLP Study Group (1995): Preventive effect of a Lactobacillus casei preparation on the recurrence of superficial bladder cancer in a double-blind trial. Eur. Urol. 27, 104-109.
3. Becton Dickinson (1989): Direct immunofluorescence staining of cell surface antigens in unseparated blood. In: Monoclonal Antibodies Source Book, Becton Dickinson: San Jose, CA, USA. section 2.11.
4. Cheng CC & Nagasawa T (1983): Associative relationships between bifidobacteria and lactobacilli in milk. Jpn J. Zootechnol. Sci. 54, 740-747.
5. Child P, Aloe M & Mee D (1987): Separation and quantitation of fatty acids, sterols and bile acids in faeces by gas chromatography as the butyl ester-acetate derivatives. J. Chromatogr. 415, 1326.
6. Cummings JH, Bingham SA, Heaton KW & Eastwood MA (1992): Faecal weight, colon cancer risk, and dietary intake of non starch polysaccharides (dietary fiber). Gastroenterology 103, 1783-1789.
7. DeSimone C, Baldinelli L, Di Fabio S, Tzantzoglou S, Jirillo E, Bianchi Salvadori B & Vesely R (1988): Lactobacilli feeding increases NK cells and γ-IFN levels in humans. In Dietics in the 90s. Role of the Dietitionist/Nutritionist, ed. MF Moyol, pp. 177-180. John Libbey Eurotext Ltd: London.
8. Faassen A, Bol J, Dokkum van W, Pikaar NA, Ockhuizen T & Hermus RJJ (1987): Bile acids, neutral sterols, and bacteria in faeces as affected by a mixed, a lacto-ovovegetarian, and a vegan diet. Am. J. Clin. Nutr. 46, 962-967.
9. Fernandes CF, Shahani KM & Amer AM (1987): Therapeutic role of dietary lactobacilli and lactobacillic fermented diary products. FEMS Microbiol. Rev. 46, 343-356.
10. Friend BA & Shahani KM (1984): Antitumor properties of lactobacilli and dairy products fermented by lactobacilli. J. Food Prot. 47, 717-723.
11. Goldin RG & Gorbach SL (1976): The relation between diet and rat faecal bacterial enzymes implicated in colon cancer. J. Natl. Cancer Inst. 57, 371-375.
12. Goldin RH, Gorbach SL, Saxelin M, Barakat S, Gualtieri L & Salmimen S (1992): Survival of Lactobacillus species (strain GG) in human gastrointestinal tract. Dig. Dis. Sci. 37, 121-128.
13. Gorter E & De Graaf WC (1955): Clinical Diagnostics (Klininische Diagnostiek), pp. 450-452. Leiden: Stenfert Kroese.
14. Halpern GM, Vruwink KG, Water van de J, Keen CL & Gershwin ME (1991): Influence of long-term yoghurt consumption in young adults. Int. J. Immunother. VII, 205-210.
15. Havenaar R & Huis in 't Veld JHJ (1992): Probiotics: a general view. In The Lactic Acid Bacteria, vol. I, ed. B.J.B. Wood, pp. 151-170. Barking: Elsevier Applied Science.
16. Havenaar R & Spanhaak S (1994): Probiotics from an immunological point of view. Curr Opin Biotechnol. 5, 320-325.
17. Hill MJ, Crawther JS, Drasar BS, Hawkswathy, Aries V & Williams REO (1971): Bacteria and etiology of cancer of large bowel. Lancet i, 95-100.
18. Isolauri E, Juntunen M, Rautanen T, Sillanaukee P & Koivula T (1991): A human Lactobacillus strain (Lactobacillus casei sp. strain GG) promotes recovery from acute diarrhoea in children. Pediatrics 88, 90-97.
19. Jacobs LR (1987): Dietary fiber and cancer. J. Nutr. 117, 1319-1321.
20. Kaila M, Isolauri E, Soppi E, Virtanen E, Laine S & Arvilommi H (1992): Enhancement of the circulating antibody secreting cell response in human diarrhoea by a human Lactobacillus strain. Pediatr. Res. 32, 141-144.
21. Kaila M, Isolauri E, Saxelin M, Arvilommi H & Vesikari T (1995): Viable versus inactivated lactobacillus strain GG in acute rotavirus diarrhoea. Arch. Dis. Child. 72, 5153.
22. Kato I, Endo K & Yokokura T (1994): Effects of oral administration of Lactobacillus casei on antitumor responses induced by tumor resection in mice. Int. J. Immunopharmacol. 16(I), 29-36.
23. LABIP (1995): Summary of the conclusions of the LAB IP-workshop on probiotics, November 1995, Frankfurt, Germany. LABIP Secretariat. Vlaardingen: URL.
24. Lê MG, Moulton LH, Hill C & Kramar A (1986): Consumption of dairy products and alcohol in a case-control study of breast cancer. J. Nat Cancer Inst. 77, 633-636.
25. Lidbeck A (1991): Studies on the impact of Lactobacillus acidophilus on human microflora and some cancer-related intestinal ecological variables. PhD Thesis, Stockholm.
26. Marteau P & Rambaud JC (1993): Potential of using lactic acid bacteria for therapy and immunomodulation in man. FEMS Microbiol. Rev. 12, 207-220.
27. Marteau P, Pochart P, Bouhnik Y & Rambaud J-C (1993): The fate and effect of transiting nonpathogenic microorganisms in the human intestine. In Intestinal Flora, Immunity, Nutrition and Health, ed. AP Simopoulos, T Corning & A Rérat. World Rev. Nutr. Diet 74, 1-21.
28. Matsuzaki T, Yokokura T & Mutai M (1985): Antitumor activity of Lactobacillus casei on Lewis carcinoma and line 10 hepatoma in syngeneic mice and guinea pigs. Cancer Immunol. Immunother. 20, 18-22.
29. Mitsuoka T (1990): Bifidobacteria and their role in human health. J. Ind. Microbiol. 6, 263-268.
30. Mulé JJ & Rosenberg SA (1992): Measurement of cytotoxic activity of LAK/NK cells. In Current Protocols in Immunology, ed. JE Coligan, AM Kruisbeek, DH Margulies, EM Shevach & W Strober, 7.18.1-7.18.7. New York: Wiley.
31. Mutai M & Tanaka R (1987): Ecology of Bifidobacterium in the human intestinal microflora. Bifidobacteria Microflora 6, 33-41.
32. Perdigon G, Nader de Marcias ME, Alvarez S, Oliver G & Pesce de Ruiz Holgado AA (1990): Prevention of gastrointestinal infection using immunobiological methods with fermented milk with Lactobacillus casei and Lactobacillus acidophilus. J. Dairy Res. 57, 255-264.
33. Pouwels PH, Leer RJ & Boersma WJA (1996): The potential of Lactobacillus as a carrier for oral immunization: development and preliminary characterization of vector systems for targeted delivery of antigens. J. Biotechnol. 44, 183-192.
34. Rafter JJ, Child P, Anderson AM, Alder R, Eng V & Bruce WR (1987): Cellular toxicity of faecal water depends on diet. Am. J. Clin. Nutr. 45, 559-563.
35. Roberfroid MB, Bornet F, Bouley C & Cummings JH (1995): Colonic microflora: nutrition and health. Summary and conclusions of an International Life Sciences Institute (ILSI Europe) workshop held in Barcelona, Spain. Nutr. Rev. 53, 127-130.
36. Sanders ME (1993): Summary of conclusions from a consensus panel of experts on health attributes of lactic cultures: significance to fluid milk products containing cultures. J. Dairy Sci. 76, 1819-1828.
37. Sanders ME (1995): Lactic acid bacteria as promoters of human health. In Functional Foods: Designer Foods, Pharmafoods, Nutraceuticals, ed. I Goldberg, pp. 294-322. London: Chapman & Hall.
38. Salminen S, Isolauri E & Salminen E (1996): Clinical uses of probiotics for stabilizing the gut mucosal barrier: successful strains and future challenges. Antonie van Leeuwenhoek 70, 347-358.
39. Saxelin M, Ahokas M & Salminen S (1993): Dose response on faecal colonisation of Lactobacillus strain GG administration in two different formulations. Microbial Ecol. Health Dis. 6, 119-122.
40. Shahani KM & Ayebo AD (1980): Role of dietary lactobacilli in gastrointestinal microecology. Am. J. Clin. Nutr. 33, 2448-2457.
41. Simon GL & Gorbach SL (1984): Intestinal flora in health and disease. Gastroenterology 86, 174-193.
42. Tanaka R (1996): The effects of the ingestion of fermented milk with Lactobacillus casei Shirota on the gastrointestinal microbial ecology in healthy subjects. In International Congress and Symposium Series 219, ed. AR Leeds & IR Rowland, pp. 37-45. London: Royal Society of Medicine Press.
43. Van 't Veer P, Dekker JM, Lamers JW, Kok FJ, Scouten EG, Brands HA, Sturmans F & Hermus RJ (1989): Consumption of fermented milk products and breast cancer: a case-control study in the Netherlands. Cancer Res. 49, 4020-4023.
44. Yamagishi T, Serikawa T, Morita R, Takahashi K & Nishida S (1974): Effect of Lactobacillus product administration on anaerobic intestinal flora of aged adults. Jpn J. Microbiol. 18, 211-216.